TO2 warrants
Background
In connection with Biosergen’s rights issue on Nasdaq First North Growth Market in October 2022, 8,595,531 warrants of series TO2 were issued. Each warrant of series TO2 entitles to subscribe for one (1) new share in Biosergen.
If all warrants of series TO2 are exercised, Biosergen will receive approximately SEK 5,673,050 million before issuing costs. Issue proceeds from the warrants of series TO2 will be used for the following:
- Operational investments
Summarized terms for the warrants of series TO2
Terms – Each warrant of series TO2 entitles the owner to subscribe for one (1) new share in Biosergen
Subscription price – 0,66 SEK per share
Exercise period – August 14, 2023 - August 25, 2023
Last day for trading warrants of series TO2 – August 22, 2023
Note – Please observe that certain nominees might close their application earlier than August 25, 2023
How warrants are exercised
Subscription for warrant holders is carried out in accordance with instructions from respective nominee or directly via an application form, as shown in below illustration. Please contact your bank for additional information.
Graphic illustration:
Important documents
Terms for warrants of series TO2 link
Letter to warrant holders - TO2 link
Press releases
Determining subscription price and first day of the exercise period - TO2 link
